C12N 2795/10362
By genetic engineering
Official title: by genetic engineering
C12N2795/10362 (By genetic engineering) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 3
- Assignees
- 5
- Inventors
- 12
- Latest grant
- 20 Aug 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Viral synthetic nucleic acid sequences and use thereof20 Aug 2024US 12,065,651 B2Synvaccine Ltd.
- Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support21 Oct 1997US 5,679,510 AHybridon, Inc.
- Modified lambda bacteriophage2 Sep 1997US 5,663,069 AMedical Science Partners
- Continuous Multiplexed Phage Genome Engineering Using a Retron Editing Template17 Jul 2025US 2025/0230429 A1The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Glads
- Viral synthetic nucleic acid sequences and use thereof28 Nov 2019US 2019/0359990 A1Synvaccine Ltd.
- Herpes Virus-Based Compositions and Methods of Use14 Aug 2008US 2008/0193416 A1University of Rochester
Most cited
By later US patents